Hyunjin Kim

1.0k total citations
69 papers, 687 citations indexed

About

Hyunjin Kim is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Hyunjin Kim has authored 69 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 22 papers in Oncology and 15 papers in Surgery. Recurrent topics in Hyunjin Kim's work include Gastric Cancer Management and Outcomes (7 papers), Gastrointestinal Tumor Research and Treatment (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Hyunjin Kim is often cited by papers focused on Gastric Cancer Management and Outcomes (7 papers), Gastrointestinal Tumor Research and Treatment (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Hyunjin Kim collaborates with scholars based in South Korea, United States and Taiwan. Hyunjin Kim's co-authors include Hyun Soo Kim, Yongdoo Choi, Kyoung‐Mee Kim, So Young Kang, Kiyong Na, Youngmi Kim, Jisu Kim, Soomin Ahn, Sangjoon Choi and Yoon Ah Cho and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Hyunjin Kim

59 papers receiving 675 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hyunjin Kim South Korea 16 227 226 152 101 87 69 687
Hao‐Lun Luo Taiwan 14 182 0.8× 230 1.0× 141 0.9× 360 3.6× 56 0.6× 80 780
Kenji Yoshida Japan 19 152 0.7× 182 0.8× 233 1.5× 140 1.4× 30 0.3× 57 838
Qingxu Song China 19 272 1.2× 226 1.0× 340 2.2× 269 2.7× 80 0.9× 44 940
Tie Chong China 18 203 0.9× 306 1.4× 420 2.8× 113 1.1× 69 0.8× 78 1.0k
Jiale Qin China 17 110 0.5× 162 0.7× 264 1.7× 45 0.4× 212 2.4× 62 793
Chengzhan Zhu China 14 166 0.7× 135 0.6× 332 2.2× 156 1.5× 87 1.0× 44 766
Raffaella Carletti Italy 16 113 0.5× 121 0.5× 193 1.3× 132 1.3× 37 0.4× 56 702
Paari Murugan United States 18 278 1.2× 329 1.5× 219 1.4× 301 3.0× 73 0.8× 69 902
Jianguang Qiu China 16 85 0.4× 228 1.0× 246 1.6× 111 1.1× 26 0.3× 52 672

Countries citing papers authored by Hyunjin Kim

Since Specialization
Citations

This map shows the geographic impact of Hyunjin Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hyunjin Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hyunjin Kim more than expected).

Fields of papers citing papers by Hyunjin Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hyunjin Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hyunjin Kim. The network helps show where Hyunjin Kim may publish in the future.

Co-authorship network of co-authors of Hyunjin Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Hyunjin Kim. A scholar is included among the top collaborators of Hyunjin Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hyunjin Kim. Hyunjin Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Jin Sung, Byung Moon Kang, Chansik An, et al.. (2025). OP02-3 Ipilimumab and nivolumab in advanced hepatocellular carcinoma after failure of prior atezolizumab and bevacizumab treatment: A multicenter retrospective study. ESMO Open. 10. 104012–104012. 1 indexed citations
2.
Gariani, Karim, Joanna Gariani, Junguee Lee, et al.. (2024). Loss of hepatic Sirt7 accelerates diethylnitrosamine (DEN)-induced formation of hepatocellular carcinoma by impairing DNA damage repair. BMB Reports. 57(2). 98–103. 2 indexed citations
4.
Park, Seyoung, Hyunjin Kim, & Eun Ryung Lee. (2023). Regional quantile regression for multiple responses. Computational Statistics & Data Analysis. 188. 107826–107826. 2 indexed citations
5.
Kim, Hyunjin, Sujin Park, So Young Kang, Soomin Ahn, & Kyoung‐Mee Kim. (2022). Peritoneal Seeding Is More Common in Gastric Cancer Patients with FGFR2 Amplification or High Tumor Mutation Burden. Diagnostics. 12(10). 2355–2355. 4 indexed citations
6.
Kim, Hyunjin, et al.. (2022). Mesonephric Adenocarcinoma of the Vagina Harboring TP53 Mutation. Diagnostics. 12(1). 119–119. 10 indexed citations
7.
Choi, Sangjoon, Su‐Jin Park, Hyunjin Kim, et al.. (2022). Gastric Cancer: Mechanisms, Biomarkers, and Therapeutic Approaches. Biomedicines. 10(3). 543–543. 28 indexed citations
8.
Kim, Hyunjin, You Jeong Heo, Yoon Ah Cho, et al.. (2021). Tumor immune microenvironment is influenced by frameshift mutations and tumor mutational burden in gastric cancer. Clinical & Translational Oncology. 24(3). 556–567. 12 indexed citations
9.
Cho, Yoon Ah, Hyunwoo Lee, Hyunjin Kim, et al.. (2021). PD-L1 Expression Is Significantly Associated with Tumor Mutation Burden and Microsatellite Instability Score. Cancers. 13(18). 4659–4659. 36 indexed citations
10.
Kim, Hyunjin, Hyunjin Kim, Kiyong Na, et al.. (2021). Mesonephric-like Adenocarcinoma of the Uterine Corpus: Comprehensive Immunohistochemical Analyses Using Markers for Mesonephric, Endometrioid and Serous Tumors. Diagnostics. 11(11). 2042–2042. 28 indexed citations
11.
Heo, You Jeong, et al.. (2021). PD-L1 expression in paired biopsies and surgical specimens in gastric adenocarcinoma: A digital image analysis study. Pathology - Research and Practice. 218. 153338–153338. 15 indexed citations
12.
Kim, Hyunjin, Hyunjin Kim, Sangjoon Choi, et al.. (2020). Clinicopathological Characteristics of Pleomorphic High-Grade Squamous Intraepithelial Lesion of the Uterine Cervix: A Single-Institutional Series of 31 Cases. Diagnostics. 10(8). 595–595. 6 indexed citations
13.
Kim, Gyuri, et al.. (2020). Protective effect of a novel clinical-grade small molecule necrosis inhibitor against oxidative stress and inflammation during islet transplantation. American Journal of Transplantation. 21(4). 1440–1452. 12 indexed citations
14.
15.
Kim, Hyunjin, et al.. (2020). Invasive Micropapillary Carcinoma of the Uterine Cervix. Case Reports in Oncology. 13(3). 1446–1453. 1 indexed citations
16.
Kim, Hyunjin, et al.. (2020). Radial neuropathy caused by intraneural leiomyoma. Medicine. 99(22). e20196–e20196. 1 indexed citations
17.
Sim, Jongmin, Hyunjin Kim, Jiyeon Hyeon, Yoon‐La Choi, & Joungho Han. (2018). Anaplastic lymphoma kinase (ALK)-expressing Lung Adenocarcinoma with Combined Neuroendocrine Component or Neuroendocrine Transformation: Implications for Neuroendocrine Transformation and Response to ALK-tyrosine Kinase Inhibitors. Journal of Korean Medical Science. 33(15). e123–e123. 5 indexed citations
18.
Kim, Jihyun, et al.. (2017). Identification of atopic dermatitis phenotypes with good responses to probiotics (Lactobacillus plantarum CJLP133) in children. Beneficial Microbes. 8(5). 755–762. 15 indexed citations
19.
Lim, Sung Hee, Jin Yong Lee, H.S. Kim, et al.. (2014). A randomized phase III trial of stereotactic radiosurgery (SRS) versus observation for patients with asymptomatic cerebral oligo-metastases in non-small-cell lung cancer. Annals of Oncology. 26(4). 762–768. 70 indexed citations
20.
Kim, Hyunjin, et al.. (2009). A gastric schwannoma presenting as an abdominal mass. The Korean Journal of Internal Medicine. 76. 44–48.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026